New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 26, 2014
13:41 EDTSIEGYSiemens files PMA for digital breast tomosynthesis
Siemens Healthcare has announced that it recently submitted to the U.S. Food and Drug Administration its premarket approval application for the MAMMOMAT Inspiration with Breast Tomosynthesis option. In this PMA submission, Siemens Healthcare has provided the FDA with clinical study results and manufacturing information. The Siemens Breast Tomosynthesis option has been designed as an add-on option for the MAMMOMAT Inspiration digital mammography system. The Siemens Breast Tomosynthesis option has been commercially available and used clinically for diagnosis since 2009 in Europe, Asia, and South America. In the U.S., the FDA classifies breast tomosynthesis as Class III, meaning that data from a clinical trial is required to measure safety and effectiveness. Class III devices require a PMA submission to the FDA for approval.
News For SIEGY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
06:29 EDTSIEGYDHS says spies targeted control systems made by Siemens, GE, WSJ reports
Subscribe for More Information
October 29, 2014
13:52 EDTSIEGYSiemens may pick buyer for hearing aid unit next week, WSJ reports
Subscribe for More Information
October 27, 2014
07:30 EDTSIEGYInternational Economic Forum of the Americas to hold a forum
Subscribe for More Information
06:22 EDTSIEGYSiemens consortium updates claimed amount in ICC arbitration
Teollisuuden Voima Oyj procured Olkiluoto 3 as a fixed-price turnkey project from the plant supplier AREVA-Siemens consortium. Both parties to the dispute have updated their estimates of costs and losses caused by the delay to the OL3 nuclear power plant project as part of their recent submissions in the International Chamber of Commerce arbitration proceedings. The updated quantification which the plant supplier submitted on October 23 brings the total amount claimed by the supplier for events occurring during the construction period ending June 2011 to approximately EUR 3.5B. Among other things, this sum includes over EUR 1.3B in respect of penalty interest and payments allegedly delayed by TVO under the plant contract, as well as approximately EUR 150M of alleged lost profit. TVO has previously considered the claims upon which the amounts demanded are based, and found them to be without merit. TVO will scrutinize the new material which has been submitted, and respond to it in due course. The arbitration proceedings may continue for several years, and the amounts claimed may be updated again. TVO has not recorded any receivables or provisions on the basis of the claims presented in the arbitration proceedings. Reference Link
October 22, 2014
08:39 EDTSIEGYSiemens sees catching up with rivals on sales growth in 2018, Reuters reports
Subscribe for More Information
October 21, 2014
10:30 EDTSIEGYSiemens discussing sale of hearing-aid unit for over $2.6B, Bloomberg says
Siemens, which had planned to sell shares in its hearing-aids division on the stock market, is now in advanced talks to sell the unit for more $2.6B, with private-equity firm EQT Partners seen as the frontrunner but other firms and companies also showing interest, according to Bloomberg, citing people familiar with the matter. Reference Link
10:03 EDTSIEGYSiemens discussing sale of hearing-aid unit for near $2.6B, Bloomberg says
Subscribe for More Information
October 17, 2014
06:23 EDTSIEGYRolls-Royce sees sale of gas turbine, compressor unit to Siemens by year end
Subscribe for More Information
October 16, 2014
09:21 EDTSIEGYSiemens signs two long-term wind service agreements in the U.S.
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use